Anti-CDK14 Antibody

This polyclonal antibody from Antibodies.com targets CDK14 (also known as PFTK1), a serine/threonine kinase of the cyclin-dependent kinase family that has been linked to G1/S cell-cycle progression, Wnt pathway regulation, and proliferation in tumor models including breast and hepatocellular carcinomas. Raised in rabbit as an IgG preparation, the reagent is supplied as 100 µl of unconjugated antiserum suitable for western blot detection of endogenous CDK14, immunohistochemistry on fixed tissue sections, and flow cytometry of human cell populations. The antibody is reactive with human CDK14 and is intended for research use only, supporting studies of kinase signaling, cell-cycle regulation, and CDK14 expression across normal and malignant tissues. For best results, aliquot the antiserum upon first thaw and store at -20 °C in single-use portions to preserve antibody activity across multiple freeze-thaw cycles. Because the reagent is polyclonal, it recognizes multiple epitopes on CDK14, which broadens detection across conformational variants of the target and improves signal in applications such as western blot and immunohistochemistry.